Pharmaceutical forms with improved pharmacokinetic properties

Details for Australian Patent Application No. 2006220100 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Serno, Peter; Heinig, Roland; Pauli, Kerstin; Hayauchi, Yutaka

Agent Davies Collison Cave

Pub. Number AU-B-2006220100

PCT Pub. Number WO2006/092207

Priority 102005009240.3 01.03.05 DE

Filing date 16 February 2006

Wipo publication date 8 September 2006

Acceptance publication date 18 August 2011

International Classifications

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/092207 Priority application(s): WO2006/092207

14 May 2009 Assignment before Grant

  Bayer HealthCare AG The application has been assigned to Bayer Schering Pharma Aktiengesellschaft

18 August 2011 Application Accepted

  Published as AU-B-2006220100

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006220107-Reduction of digestibility of phosphorus in animal nutrition

2006220097-Derivatives of aminobutanoic acid inhibiting CPT